ID   PC-8
AC   CVCL_4Z01
SY   PC 8
DR   ChEMBL-Cells; CHEMBL3307866
DR   ChEMBL-Targets; CHEMBL614101
DR   PubChem_Cell_line; CVCL_4Z01
DR   Wikidata; Q54938467
RX   PubMed=758928;
RX   PubMed=1367039;
RX   PubMed=3902783;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
RX   PubMed=758928; DOI=10.1038/bjc.1979.3; PMCID=PMC2009802;
RA   Kinjo, Mitsuru
RA   Oka, Kazunari
RA   Naito, S.
RA   Kohga, Shin
RA   Tanaka, Kenzo
RA   Oboshi, Shoichi
RA   Hayata, Yoshihiro
RA   Yasumoto, Kosei
RT   "Thromboplastic and fibrinolytic activities of cultured human cancer
RT   cell lines.";
RL   Br. J. Cancer 39:15-23(1979).
//
RX   PubMed=1367039; DOI=10.1007/BF00365092;
RA   Shinmoto, Hiroshi
RA   Dosako, Shun-ichi
RA   Yamada, Koji
RA   Shirahata, Sanetaka
RA   Murakami, Hiroki
RT   "Purification and some properties of proliferation suppressing factor
RT   from human lung adenocarcinoma PC-8.";
RL   Cytotechnology 4:121-126(1990).
//
RX   PubMed=3902783; DOI=10.1007/BF02620891;
RA   Murakami, Hiroki
RA   Hashizume, Shuichi
RA   Ohashi, Hideya
RA   Shinohara, Kazuki
RA   Yasumoto, Kosei
RA   Nomoto, Kikuo
RA   Omura, Hirohisa
RT   "Human-human hybridomas secreting antibodies specific to human lung
RT   carcinoma.";
RL   In Vitro Cell. Dev. Biol. 21:593-596(1985).
//